Khiron Life Sciences Corp.
Rank 60
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
$0.3583
USD
0.00%
Market cap
$40,816,897
Total volume
$106,228
Shares outstanding
113,927,120
Rank 60
About
Predominately a pharmaceutical company, Khiron Life Sciences uses several subsidiaries to develop and commercialise medical-grade cannabis. Through Khiron Colombia and Kuida Life Mexico, it provides services to Canada and parts of Latin America. They also sponsor clinical trials alongside an e-learning platform available to patients.
Markets
| Exchange | Symbol | Volume (24h) | Volume (%) | Price |
|---|---|---|---|---|
|
|
KHRN |
$91,701
|
86.32% |
$0.3583
|
| KHRNF |
Total volume
$14,527
|
13.68% |
Stock price
$0.4213
|
Chart